Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage

NCT03194932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: Cytarabine
DRUG: Idarubicin
DRUG: Intrathecal Triple Therapy
DRUG: Azacitidine

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]